Searched for
CIPLA NON EXECUTIVE
Cipla shares in focus as promoters Samina and Rumana Hamied offload 1.72% stake for Rs 2,111 croreCipla shares are in focus today after Samina Hamied and Rumana Hamied, promoters of the pharmaceutical company, exited by selling their 1.7...- Promoters Samina and Rumana Hamied exit Cipla; sell 1.72 pc stake for Rs 2,111 croreSamina Hamied and Rumana Hamied, promoters of drug major Cipla, on Monday exited the pharmaceutical company by selling their 1.72 per cent ...
- Cipla's vice-chairman MK Hamied resigns citing age and health, his son Kamil to join the boardCipla's vice-chairman MK Hamied has resigned from the board due to age and health concerns, effective October 29, 2024. His son Kamil Hamie...
- Cipla's MK Hamied resigns from the company due to health reasonsCipla's Vice Chairman and Non-Executive Director, Mr. M K Hamied, has resigned from his position due to age and health reasons. His resigna...
- Cipla promoters sell 2.53% stake for Rs 2,751 crore"Post transaction, the entire promoter group, including persons acting in concert, continues to hold 31.67% in the company and remains comm...
- Samina Hamied of Cipla steps down from her executive roleSamina Hamied, executive vice-chairperson of Cipla, announced her decision to step down from her executive role due to personal and family ...
- Samina Hamied to step down as Cipla executive vice chairpersonDrug major Cipla on Thursday said Samina Hamied has decided to step down from the position of Executive Vice Chairperson of the company, wh...
- Cipla founding family’s stake sale in jeopardy over $13 billion valuation targetProspective buyers of a stake in Indian pharmaceutical company Cipla Ltd. are hesitant due to the high valuation demanded by the founding f...
- Blackstone sets its sights on buying out Hamieds from CiplaNon-binding bid likely next week for 33.4% stake, will trigger open offer for 26% more. At current mkt value deal size could be over $6 bn ...
- Cipla tanks 5% as promoters sell stake in block dealDr Y K Hamied, Chairman and MK Hamied, Vice Chairman who are Non-Executive Directors and promoters, have sold 2,01,69,756 shares, represent...
- India getting ready for COVID-19 vaccines: Sadananda GowdaLaunching the Annual Summit 2020 of industry body OPPI, Gowda also said that the contribution of Indian pharmaceutical sector has been rein...
- Cipla divests animal health business in South Africa, sub-Saharan AfricaThe deal comes with a potential revision linked to FY17 performance along with customary adjustment (within the price band of 250 mn Rand a...
- Cipla appoints Peter Lankau as independent directorLankau is currently a principal of Lankau Consulting LLC. He serves on the Board of Directors of ANI Pharmaceuticals Inc and Phosphagenics ...
- Cipla appoints Ireena Vittal as independent directorCipla is in the midst of preparing itself for an exciting future and her background of both business and advisory will be very useful to th...
- Cipla names Samina Vaziralli as Executive Vice-ChairmanVaziralli, daughter of MK Hamied -- the company's non-executive VC - has been a part of the core leadership team since joining the Mumbai-b...
- Cipla patriarch Y K Hamied increases stake in company to over 20%The transfer of shares is being done by way of gift, the filing said, adding that the purpose was "Re-alignment of family shareholding".
- YK Hamied to increase stake in Cipla to over 20 per centCipla patriarch YK Hamied plans to increase his holding to over 20 per cent by acquiring over 5 per cent additional stake in the homegrown ...
- Cipla appoints Naina Lal Kidwai as an independent directorIndia's third largest drug maker Cipla has appointed Naina Lal Kidwai on its board as an independent director.
- Cipla board approves retirement of MK HamiedDrug firm Cipla today approved the retirement of its Executive Vice-Chairman, M K Hamied with effect from March 31, 2014.
- Cipla, DNDi to launch new malaria drugDNDi is a not-for-profit research and development organisation working to deliver new treatments for neglected diseases.
Load More
